Alison A. Evans
Drexel University School of Public Health
Alison A. Evans, Sc.D. is an associate professor in the Department of Epidemiology and Biostatistics at Drexel University Dornsife School of Public Health. She is also adjunct research faculty in the Public Health Program of the Hepatitis B Foundation, Doylestown, PA. Prior to joining Drexel, she was an associate member at the Fox Chase Cancer Center. Her research interests include the epidemiology and natural history of the hepatitis B virus and other chronic viral infections, the association of chronic viral infections with cancer, and public health interventions to decrease the burden of HBV infection globally. She received her ScD in epidemiology from the Harvard School of Public Health.
Robert Wood Johnson Foundation
Paul Kuehnert, D.N.P., R.N., F.A.A.N., is a nurse and public health expert who currently oversees RWJF's work in building bridges among the health care system, public health, and other community services and agencies to improve overall population health. As a former county health officer in Illinois and former deputy state health officer in Maine, he brings extensive public health experience to the group. He has an acute awareness of the strengths of local and state public health agencies in combatting conditions such as hepatitis B and C as well as the challenges they face. He is extremely familiar with the topics of surveillance, implementation of disease control programs, screening, epidemiology, and community based program implementation (see in particular his prior work in HIV/AIDS).
Vincent Lo Re, III
University of Pennsylvania
Vincent Lo Re III, M.D., M.S.C.E., earned his medical degree from the University of Pennsylvania, completed an internship and residency in internal medicine and completed a fellowship in infectious diseases at the Hospital of the University of Pennsylvania. He also earned a Master of Science in clinical epidemiology degree from the University of Pennsylvania. Dr. Lo Re has a nationally recognized clinical research program in viral hepatitis epidemiology. He joined the Penn faculty in 2008 and is currently an assistant professor of medicine in the Division of Infectious Diseases and assistant professor of epidemiology in the Department of Biostatistics and Epidemiology at Penn. He is also co-director of the HIV/Viral Hepatitis Scientific Working Group within the Penn Center for AIDS Research and a senior scholar in the Penn Center for Clinical Epidemiology and Biostatistics. Additionally, he is co-chair of the Liver Core of the Veterans Aging Cohort Study. He has been invited to speak on topics related to chronic viral hepatitis infection, HIV/viral hepatitis coinfection, and pharmacoepidemiology at ID Week, the Interscience Conference on Antimicrobial Agents and Chemotherapy, Conference on Retroviruses and Opportunistic Infections, FDA, and the International Society for Pharmacoepidemiology. He has been a standing member of the FDA’s Antiviral Drug (now Anti-Infective) Advisory Committee since 2014. He also served as a member of the National Institute of Allergy and Infectious Diseases study section reviewing the Centers of Excellence for Influenza Research and Surveillance.
Connecticut Department of Correction
Kathleen Maurer, M.D., M.P.H., M.B.A., is the Connecticut Department of Correction’s director of health and addiction services and medical director. Before assuming her current post in 2011, she was assistant medical director at Correctional Managed Health Care, a division of the University of Connecticut Health Center, which contracts with the state corrections department for offender medical care. During her career, Dr. Maurer has provided hands-on clinical care and medical program management in the private sector. In the realm of correctional care, she is particularly interested in the quality of patient care, in the role of correctional healthcare in the broader scope of public health such as in the treatment of hepatitis C virus in our offender-patients, and in facilitating re-entry programs through integration of community and correctional healthcare. Several of her recent and ongoing initiatives include working to expand Medicaid access to halfway house residents and to integrate Medicaid utilization management with the correctional system. She is also developing a system-wide medication assisted therapy program for the Connecticut DOC. Dr. Maurer is the primary author of the monograph entitled “Hepatitis C in Correctional Settings: Challenges and Opportunities,” and published by the American Correctional Association. Dr. Maurer earned her MD from Yale University School of Medicine. She also earned an MPH from Yale. She holds an MBA from the University of Connecticut and is board-certified in internal medicine, occupational and environmental medicine, and addiction medicine.
Randall R. Mayer
Iowa Department of Public Health
Randall R. Mayer, M.S., M.P.H. serves as interim director of the Division of Behavioral Health at the Iowa Department of Public Health. While working with the Iowa Department of Public Health, Mr. Mayer served as the chief of the Bureau of HIV, STD, and Hepatitis, HIV surveillance coordinator and the HIV and Hepatitis program manager. He received his MPH in epidemiology from the University of Minnesota and his MS in plant cell physiology from Purdue University.
Johns Hopkins University
Dr. Shruti Mehta, Ph.D., M.P.H., is a professor in the Johns Hopkins Bloomberg School of Public Health. Her primary research interests include working with hard-to reach populations to understand the epidemiology, natural and treated history of HIV, hepatitis C virus (HCV) and HIV/HCV co-infection; Populations of interest include injection drug users and men who have sex with men as well as their sexual partners in both Baltimore and international settings, particularly India; Special interest in identifying and overcoming barriers to care and treatment of HIV and hepatitis C virus among such populations.
Stuart C. Ray
Johns Hopkins Bloomberg School of Public Health
Stuart C. Ray, M.D. serves as vice chair of medicine for Data Integrity and Analytics, associate fellowship program director and professor in the Division of Infectious Diseases within the Department of Medicine, with secondary appointments in Viral Oncology and Health Sciences Informatics, at the Johns Hopkins University School of Medicine. He directs the virology laboratory and is a clinical investigator in the Center for Viral Hepatitis Research in the Division of Infectious Diseases. He is a faculty member of the graduate immunology program, the graduate pharmacology program, and of the Janeway Firm of the Osler Medical Service. Dr. Ray received his M.D. from Vanderbilt University School of Medicine in 1990. After an internship and residency at Johns Hopkins Hospital, he continued there as an assistant chief of service and fellow in infectious diseases. During his fellowship, he studied the immunology and sequence variation of HIV in the laboratory of Dr. Robert Bollinger. During that time, he developed an interest in HIV sequence variation during antiretroviral therapy in a productive collaboration with Dr. Robert Siliciano that continues to the present.
In 1997, Dr. Ray joined the Johns Hopkins faculty, and under the mentorship of Dr. David Thomas shifted his primary research focus to hepatitis C virus (HCV). His laboratory work has focused on the sequence variation of HCV during acute and chronic infection, developing and applying computational and molecular biology tools to underlying mechanisms including stochastic variation, immune selection, and viral fitness. He continues to care for inpatients and outpatients with HIV, HCV, and other infectious diseases.
Arthur L. Reingold
University of California, Berkeley
Arthur Reingold, M.D., is Edward Penhoet Distinguished Professor of Global Health and Infectious Diseases at the School of Public Health, University of California, Berkeley (UCB). He is also professor of epidemiology and biostatistics and clinical professor of medicine at the University of California, San Francisco (UCSF). His research interests include emerging and reemerging infections and vaccine-preventable diseases in the United States and developing countries. Reingold serves on the World Health Organization's Strategic Advisory Group of Experts on vaccines and vaccine policy as vice-chair. He is also director of the California Emerging Infections Program, and of the U.S. National Institutes of Health Fogarty AIDS International Training and Research Program at the UCB/UCSF. His recent publications include articles on the impact of the introduction of pneumococcal conjugate vaccine in the United States and related topics. Before joining the faculty at UCB, Reingold worked for eight years at the Centers for Disease Control and Prevention. He is a member of the National Academy of Medicine.
Stanford University School of Medicine
Samuel So, M.B. is a professor of surgery and the Lui Hac Minh Professor at Stanford University. He is also the director of the Asian Liver Center and director of the Multidisciplinary Liver Cancer Program at the same institution. He has published numerous studies on solid organ transplantation, gastric and liver cancers. Dr. So is well known for his work on hepatitis B and liver cancer education and prevention programs. Through his research, Dr. So has identified the need for a public health approach to liver cancer prevention among recent Asian immigrants and first and second generation Asians living in the US. These populations have not been the typical focus of US screening and prevention programs. Dr. So is listed among the Best Doctors in America published by Woodward/White Inc. For his work in education and prevention, he received the 2005 National Leadership Award from the New York University Center for the Study of Asian American Health, and the 2008 American Liver Foundation Salute to Excellence Award. He is a member of the IOM's Board on Population Health and Public Health Practice. Dr. So received his MB, BS in medicine and surgery from the University of Hong Kong, and did postdoctoral and clinical fellowships at the University of Minnesota.
Neeraj Sood, Ph.D., is and Associate Professor and Vice Dean for Research at the USC Schaeffer Center and Sol Price School of Public Policy. In addition, he currently serves as the Director of Research at the Leonard D. Schaeffer Center for Health Policy and Economics and is an Associate Professor at the Price School and the School of Pharmacy’s Department of Pharmaceutical and Health Economics. His prior work has focused on the economics of innovation, HIV/AIDS, health care financing, and global health.
His research has been published in several peer-reviewed journals and books including leading journals in economics, medicine and health policy. He has testified frequently on health policy issues before state legislators and his work has also been featured in several media outlets including the New York Times, Washington Post, U.S. News and World Report, and Scientific American. Dr. Sood was the finalist for the 16th and 21st Annual NIHCM Health Care Research Award, recognizing outstanding research in health policy. He was also the 2009 recipient of the Eugene Garfield Economic Impact Prize, recognizing outstanding research demonstrating how medical research impacts the economy.
Dr. Sood is on the editorial boards of Health Services Research and Forum for Health Economics and Policy and is a research associate at the National Bureau of Economic Research (NBER). Prior to joining USC, Dr. Sood was a senior economist at RAND and Professor at the Pardee RAND Graduate School.
International Community Health Services
Grace Wang, M.D., is a board certified family physician for International Community Health Services in Seattle, Washington. Dr. Wang graduated from the University of Michigan with a degree in Early Childhood Education. She received her medical training at Cornell University Medical College in New York City and has a Master’s in Public Health also from the University of Michigan. Dr. Wang has worked in primary care and public health in New York City and Seattle. She is currently a member of the Executive Committee for the National Association of Community Health Centers (NACHC) Board of Directors and also serves on the boards for Project Access Northwest and Kin On.
Lucy E. Wilson
Department of Health and Mental Hygiene
Lucy Wilson, M.D., Sc.M., is a Medical Epidemiologist and infectious disease physician at the Maryland Department of Health and Mental Hygiene, where she serves as the Chief of the Center for Surveillance, Infection Prevention and Outbreak Response. At the State of Maryland, Dr. Wilson implements surveillance and prevention of reportable infectious diseases (including hepatitis B and C infections), consults on infection control issues across the healthcare continuum and in the general community, and oversees Maryland’s outbreak responses, including food-related outbreaks, novel influenza pandemic response, and Ebola Virus Disease response. Dr. Wilson is the Principal Investigator of the Healthcare Associated Infections (HAI) branch of the CDC/Maryland Emerging Infections Program, conducting HAI surveillance and prevention research and is the medical advisor for the CDC grant “Community-based Programs to Test and Cure Hepatitis C” in Maryland. Dr. Wilson is an adjunct assistant professor at the Johns Hopkins University School of Medicine, where she previously was on the Johns Hopkins School of Medicine Division of Infectious Diseases faculty as the Medical Director of the Johns Hopkins HIV County Program, and where her research focused on the natural history of hepatitis C in injection drug users and HIV clinical outcomes research.
Gillian Buckley - (Staff Officer)
Institute of Medicine